Name: Veterinary Dermatology Market by Route of Administration, Product type (Antibacterial, Antifungal, Antiparasitic Drugs, Monoclonal Antibodies), Condition type (Parasitic Infections, Infectious Diseases, Skin Cancer), Animal type - Global Forecast to 2030
Brand: MarketsandMarkets
SKU: MD9319
Price: 4950 USD
Availability: InStock

1 INTRODUCTION 32 1.1 STUDY OBJECTIVES 32 1.2 MARKET DEFINITION 33 1.2.1 INCLUSIONS AND EXCLUSIONS 33 1.3 STUDY SCOPE 34 1.3.1 YEARS CONSIDERED 35 1.4 CURRENCY CONSIDERED 35 1.5 STAKEHOLDERS 36 2 RESEARCH METHODOLOGY 37 2.1 RESEARCH APPROACH 37 2.1.1 SECONDARY DATA 38 2.1.1.1 Key data from secondary sources 40 2.1.2 PRIMARY DATA 40 2.1.2.1 Key data from primary sources 42 2.1.2.2 Key industry insights 43 2.2 MARKET SIZE ESTIMATION 45 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 51 2.4 MARKET SHARE ESTIMATION 51 2.5 RESEARCH ASSUMPTIONS 52 2.6 RISK ASSESSMENT 52 2.7 RESEARCH LIMITATIONS 53 2.7.1 METHODOLOGY-RELATED LIMITATIONS 53 2.7.2 SCOPE-RELATED LIMITATIONS 53 3 EXECUTIVE SUMMARY 54 4 PREMIUM INSIGHTS 60 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN VETERINARY DERMATOLOGY MARKET 60 4.2 NORTH AMERICA: VETERINARY DERMATOLOGY MARKET OVERVIEW 61 4.3 VETERINARY DERMATOLOGY MARKET: REGIONAL MIX 62 4.4 VETERINARY DERMATOLOGY MARKET, BY COUNTRY 62 4.5 VETERINARY DERMATOLOGY MARKET: EMERGING VS. DEVELOPED MARKETS 63 5 MARKET OVERVIEW 64 5.1 INTRODUCTION 64 5.2 MARKET DYNAMICS 65 5.2.1 DRIVERS 65 5.2.1.1 Expanding companion animal population and pet ownership 65 5.2.1.2 Growing concerns about infectious zoonotic diseases 68 5.2.1.3 Rising awareness initiatives by government and animal welfare organizations 70 5.2.1.4 Increasing adoption of pet insurance and high animal healthcare expenditure 70 5.2.2 RESTRAINTS 72 5.2.2.1 Rising pet care costs 72 5.2.2.2 Restrictions on use of parasiticides for food-producing animals 72 5.2.3 OPPORTUNITIES 73 5.2.3.1 Technological advancements and product launches 73 5.2.3.2 High growth potential in emerging economies 73 5.2.3.3 Surging number of veterinary practitioners in developed markets 74 5.2.4 CHALLENGES 75 5.2.4.1 Growing resistance to parasiticides 75 5.2.4.2 Diversity in parasite species 76 5.3 INDUSTRY TRENDS 76 5.3.1 RISE IN PET OWNERSHIP, HUMANIZATION OF PETS, AND INCREASED FOCUS ON PET WELLNESS PROGRAMS 76 5.3.2 RISING USE OF DIAGNOSTICS AND WEARABLE TECHNOLOGY FOR EARLY DETECTION 76 5.4 TECHNOLOGY ANALYSIS 77 5.4.1 KEY TECHNOLOGIES 77 5.4.1.1 Topical nanomedicine 77 5.4.1.2 Biologic therapies 77 5.4.2 COMPLEMENTARY TECHNOLOGIES 78 5.4.2.1 Phototherapy 78 5.4.2.2 Hydrotherapy 78 5.4.3 ADJACENT TECHNOLOGIES 78 5.4.3.1 Telemedicine platforms 79 5.4.3.2 Wearable devices 79 5.5 PORTER’S FIVE FORCES ANALYSIS 79 5.5.1 COMPETITIVE RIVALRY 80 5.5.1.1 Established players 80 5.5.1.2 Continuous innovation 80 5.5.2 BARGAINING POWER OF BUYERS 80 5.5.2.1 Consolidated veterinary groups 80 5.5.2.2 Demand for affordable solutions 80 5.5.3 BARGAINING POWER OF SUPPLIERS 80 5.5.3.1 Specialized raw materials 80 5.5.3.2 Quality compliance 80 5.5.4 THREAT OF SUBSTITUTES 81 5.5.4.1 Limited alternatives 81 5.5.4.2 Specialized treatments 81 5.5.5 THREAT OF NEW ENTRANTS 81 5.5.5.1 High R&D costs 81 5.5.5.2 Regulatory requirements 81 5.6 REGULATORY LANDSCAPE 82 5.6.1 REGULATORY ANALYSIS 82 5.6.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 85 5.7 PATENT ANALYSIS 87 5.7.1 PATENT PUBLICATION TRENDS FOR VETERINARY DERMATOLOGY MARKET 87 5.7.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 88 5.8 TRADE ANALYSIS 91 5.8.1 IMPORT AND EXPORT SCENARIO FOR VETERINARY DERMATOLOGY PRODUCTS 91 5.9 PRICING ANALYSIS 92 5.9.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT TYPE 92 5.9.2 AVERAGE SELLING PRICE TREND OF VETERINARY DERMATOLOGY PRODUCT TYPES, BY REGION 93 5.10 REIMBURSEMENT ANALYSIS 95 5.11 KEY CONFERENCES AND EVENTS 96 5.12 KEY STAKEHOLDERS AND BUYING CRITERIA 97 5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 97 5.12.2 BUYING CRITERIA 97 5.13 UNMET NEEDS/END USER EXPECTATIONS IN VETERINARY DERMATOLOGY MARKET 98 5.14 IMPACT OF GENERATIVE AI ON VETERINARY DERMATOLOGY MARKET 99 5.15 ECOSYSTEM ANALYSIS 99 5.16 CASE STUDY ANALYSIS 101 5.16.1 ZOETIS LAUNCHED APOQUEL TABLET FOR ALLERGIC DERMATITIS 101 5.16.2 ELANCO LAUNCHED ZENRELIA TABLET FOR CANINE ATOPIC DERMATITIS 102 5.16.3 VIRBAC LAUNCHED ALLERDERM SPOT-ON TOPICAL PRODUCT FOR SKIN BARRIER REPAIR 102 5.17 SUPPLY CHAIN ANALYSIS 103 5.18 VALUE CHAIN ANALYSIS 104 5.19 ADJACENT MARKETS FOR VETERINARY DERMATOLOGY MARKET 105 5.20 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 106 5.21 INVESTMENT AND FUNDING SCENARIO 107 6 VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION 108 6.1 INTRODUCTION 109 6.2 TOPICAL 109 6.2.1 HIGH PREVALENCE OF ECTOPARASITIC INFESTATIONS AMONG PETS TO DRIVE DEMAND 109 6.3 INJECTABLES 113 6.3.1 RAPID ABSORPTION AND HIGH BIOAVAILABILITY TO FUEL GROWTH OF INJECTABLE PRODUCTS 113 6.4 ORAL 115 6.4.1 COMPREHENSIVE APPROACH TO MANAGING CHRONIC AND SEVERE DERMATOLOGICAL DISORDERS 115 7 VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE 117 7.1 INTRODUCTION 118 7.2 ANTIPARASITIC DRUGS 118 7.2.1 HIGH PREVALENCE OF PARASITIC INFECTIONS IN ANIMALS TO DRIVE DEMAND 118 7.3 ANTIFUNGAL DRUGS 122 7.3.1 INCREASING INSTANCES OF YEAST DERMATITIS AND CANDIDIASIS TO DRIVE DEMAND 122 7.4 ANTIBACTERIAL DRUGS 125 7.4.1 GROWTH HINDERED BY RISING CONCERNS OVER ANTIMICROBIAL RESISTANCE 125 7.5 MONOCLONAL ANTIBODIES 127 7.5.1 RISING INVESTMENT IN R&D TO BOOST SEGMENTAL GROWTH 127 7.6 OTHER PRODUCT TYPES 129 8 VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE 131 8.1 INTRODUCTION 132 8.2 PARASITIC INFECTIONS 132 8.2.1 HIGH OCCURRENCE IN BOTH COMPANION AND LIVESTOCK ANIMALS TO DRIVE DEMAND FOR PREVENTIVE MEASURES 132 8.3 INFECTIOUS DISEASES 134 8.3.1 HIGH PREVALENCE OF FUNGAL INFECTIONS TO DRIVE GROWTH 134 8.4 AUTOIMMUNE SKIN DISEASES 136 8.4.1 LOWER OCCURRENCE OF THESE DISEASES CONTRIBUTE TO SMALLER MARKET SHARE 136 8.5 SKIN CANCER 138 8.5.1 GROWING AWARENESS ABOUT IMPORTANCE OF EARLY DETECTION AND TREATMENT OF SKIN CANCER TO DRIVE GROWTH 138 8.6 OTHER CONDITION TYPES 140 9 VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE 142 9.1 INTRODUCTION 143 9.2 COMPANION ANIMALS 143 9.2.1 DOGS 146 9.2.1.1 Growing dog population and high pet ownership to drive growth 146 9.2.2 CATS 148 9.2.2.1 Growing awareness of feline health to drive growth 148 9.2.3 HORSES 150 9.2.3.1 Initiatives related to adoption to drive growth 150 9.2.4 OTHER COMPANION ANIMALS 152 9.3 LIVESTOCK ANIMALS 154 9.3.1 CATTLE 156 9.3.1.1 Economic importance of dairy and beef cattle to drive growth 156 9.3.2 SWINE 158 9.3.2.1 Rising global swine population and pork consumption to drive growth 158 9.3.3 POULTRY 160 9.3.3.1 Increasing demand for milk and dairy products to drive growth 160 9.3.4 OTHER LIVESTOCK ANIMALS 162 10 VETERINARY DERMATOLOGY MARKET, BY END USER 164 10.1 INTRODUCTION 165 10.2 VETERINARY HOSPITALS AND CLINICS 165 10.2.1 GROWING DEMAND FOR SPECIALIZED SKINCARE AND TREATMENTS TO DRIVE MARKET 165 10.3 ANIMAL SHELTERS AND RESCUES 167 10.3.1 NGO AND ANIMAL WELFARE ORGANIZATIONS TO KEEP SUPPORTING DERMATOLOGICAL TREATMENT IN VETERINARY MARKET 167 10.4 OTHER END USERS 169 11 VETERINARY DERMATOLOGY MARKET, BY REGION 171 11.1 INTRODUCTION 172 11.2 NORTH AMERICA 173 11.2.1 MACROECONOMIC OUTLOOK 173 11.2.2 US 179 11.2.2.1 High pet ownership rates to drive growth 179 11.2.3 CANADA 183 11.2.3.1 Rising concerns about pet skin health to drive market 183 11.3 EUROPE 187 11.3.1 MACROECONOMIC OUTLOOK 187 11.3.2 GERMANY 192 11.3.2.1 Rising poultry consumption and dairy industry to drive market 192 11.3.3 UK 196 11.3.3.1 Large pet ownership and zoonotic disease prevention to drive market 196 11.3.4 FRANCE 200 11.3.4.1 Stable animal healthcare spending to support market growth 200 11.3.5 ITALY 203 11.3.5.1 Expanding livestock industry to drive market 203 11.3.6 SWITZERLAND 206 11.3.6.1 High standards in animal health to drive growth 206 11.3.7 SPAIN 210 11.3.7.1 Growing pet population and strong dairy industry to drive market 210 11.3.8 REST OF EUROPE 213 11.4 ASIA PACIFIC 217 11.4.1 MACROECONOMIC OUTLOOK 217 11.4.2 JAPAN 223 11.4.2.1 Rising demand for animal products and increasing pet ownership to drive growth 223 11.4.3 CHINA 227 11.4.3.1 Expanding urban pet market and high meat consumption to fuel market 227 11.4.4 INDIA 231 11.4.4.1 Growing pet adoption and veterinary shortage to drive market 231 11.4.5 AUSTRALIA 235 11.4.5.1 Growing pet ownership and rising spending on veterinary care to drive market 235 11.4.6 NEW ZEALAND 238 11.4.6.1 Increased pet ownership and demand for advanced dermatology treatments to drive market 238 11.4.7 SOUTH KOREA 242 11.4.7.1 Increasing awareness and adoption of preventive healthcare measures to drive market 242 11.4.8 REST OF ASIA PACIFIC 245 11.5 LATIN AMERICA 249 11.5.1 MACROECONOMIC OUTLOOK 249 11.5.2 BRAZIL 254 11.5.2.1 Strong veterinary infrastructure and expanding livestock industry to drive market 254 11.5.3 MEXICO 258 11.5.3.1 Expanding livestock and poultry sectors to drive market 258 11.5.4 REST OF LATIN AMERICA 261 11.6 MIDDLE EAST & AFRICA 264 11.6.1 MACROECONOMIC OUTLOOK 264 11.6.2 GCC COUNTRIES 268 11.6.2.1 Kingdom of Saudi Arabia (KSA) 271 11.6.2.1.1 Vision 2030 investments to drive market 271 11.6.2.2 United Arab Emirates (UAE) 274 11.6.2.2.1 Significant livestock population to fuel demand 274 11.6.2.3 Rest of GCC Countries 277 11.6.3 REST OF MIDDLE EAST & AFRICA 280 12 COMPETITIVE LANDSCAPE 284 12.1 OVERVIEW 284 12.2 KEY PLAYER STRATEGY/RIGHT TO WIN 284 12.3 REVENUE ANALYSIS OF KEY PLAYERS IN VETERINARY DERMATOLOGY MARKET (2020–2024) 285 12.4 MARKET SHARE ANALYSIS, 2024 286 12.4.1 RANKING OF KEY MARKET PLAYERS, 2024 289 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 289 12.5.1 STARS 289 12.5.2 EMERGING LEADERS 289 12.5.3 PERVASIVE PLAYERS 289 12.5.4 PARTICIPANTS 290 12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 291 12.5.5.1 Company footprint 291 12.5.5.2 Region footprint 292 12.5.5.3 Route of administration footprint 293 12.5.5.4 Product type footprint 294 12.5.5.5 Condition type footprint 295 12.5.5.6 Animal type footprint 296 12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 297 12.6.1 PROGRESSIVE COMPANIES 297 12.6.2 RESPONSIVE COMPANIES 297 12.6.3 DYNAMIC COMPANIES 297 12.6.4 STARTING BLOCKS 297 12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 299 12.7 BRAND/PRODUCT COMPARISON 301 12.8 R&D EXPENDITURE OF KEY PLAYERS 302 12.9 COMPANY VALUATION AND FINANCIAL METRICS 302 12.9.1 COMPANY VALUATION 302 12.9.2 FINANCIAL METRICS 303 12.10 COMPETITIVE SCENARIO 303 12.10.1 PRODUCT APPROVALS/LAUNCHES 303 12.10.2 DEALS 304 12.10.3 EXPANSIONS 305 12.10.4 OTHER DEVELOPMENTS 306 13 COMPANY PROFILES 307 13.1 KEY PLAYERS 307 13.1.1 ELANCO ANIMAL HEALTH INCORPORATED 307 13.1.1.1 Business overview 307 13.1.1.2 Products offered 308 13.1.1.3 Recent developments 310 13.1.1.3.1 Product launches and approvals 310 13.1.1.3.2 Deals 310 13.1.1.3.3 Expansions 311 13.1.1.4 MnM view 311 13.1.1.4.1 Right to win 311 13.1.1.4.2 Strategic choices 311 13.1.1.4.3 Weaknesses and competitive threats 312 13.1.2 MERCK & CO., INC 313 13.1.2.1 Business overview 313 13.1.2.2 Products offered 314 13.1.2.3 Recent developments 315 13.1.2.3.1 Product launches and approvals 315 13.1.2.3.2 Deals 316 13.1.2.3.3 Expansions 317 13.1.2.3.4 Other developments 317 13.1.2.4 MnM view 317 13.1.2.4.1 Right to win 317 13.1.2.4.2 Strategic choices 318 13.1.2.4.3 Weaknesses and competitive threats 318 13.1.3 VIRBAC 319 13.1.3.1 Business overview 319 13.1.3.2 Products offered 320 13.1.3.3 Recent developments 321 13.1.3.3.1 Deals 321 13.1.3.3.2 Expansions 322 13.1.3.3.3 Other developments 322 13.1.3.4 MnM view 322 13.1.3.4.1 Right to win 322 13.1.3.4.2 Strategic choices 323 13.1.3.4.3 Weaknesses and competitive threats 323 13.1.4 ZOETIS INC. 324 13.1.4.1 Business overview 324 13.1.4.2 Products offered 325 13.1.4.3 Recent developments 326 13.1.4.3.1 Product launches and approvals 326 13.1.4.3.2 Deals 327 13.1.4.3.3 Expansions 327 13.1.4.3.4 Other developments 328 13.1.4.4 MnM view 328 13.1.4.4.1 Right to win 328 13.1.4.4.2 Strategic choices 328 13.1.4.4.3 Weaknesses and competitive threats 329 13.1.5 BOEHRINGER INGELHEIM INTERNATIONAL GMBH 330 13.1.5.1 Business overview 330 13.1.5.2 Products offered 331 13.1.5.3 Recent developments 332 13.1.5.3.1 Product approvals 332 13.1.5.3.2 Deals 332 13.1.5.4 MnM view 332 13.1.5.4.1 Right to win 332 13.1.5.4.2 Strategic choices 333 13.1.5.4.3 Weaknesses and competitive threats 333 13.1.6 VETOQUINOL 334 13.1.6.1 Business overview 334 13.1.6.2 Products offered 335 13.1.6.3 Recent developments 336 13.1.6.3.1 Product approvals 336 13.1.7 DECHRA PHARMACEUTICALS PLC 337 13.1.7.1 Business overview 337 13.1.7.2 Products offered 338 13.1.7.3 Recent developments 339 13.1.7.3.1 Product approvals 339 13.1.7.3.2 Deals 340 13.1.8 HESTER BIOSCIENCES LIMITED 341 13.1.8.1 Business overview 341 13.1.8.2 Products offered 343 13.1.9 PETIQ, INC. 344 13.1.9.1 Business overview 344 13.1.9.2 Products offered 345 13.1.9.3 Recent developments 346 13.1.9.3.1 Other developments 346 13.1.10 OUROFINO SAUDE ANIMAL 347 13.1.10.1 Business overview 347 13.1.10.2 Products offered 348 13.1.11 SWEDENCARE 349 13.1.11.1 Business overview 349 13.1.11.2 Products offered 350 13.1.11.3 Recent developments 351 13.1.11.3.1 Deals 351 13.1.12 ORION CORPORATION 353 13.1.12.1 Business overview 353 13.1.12.2 Products offered 354 13.1.13 NORBROOK 355 13.1.13.1 Business overview 355 13.1.13.2 Products offered 356 13.1.13.3 Recent developments 357 13.1.13.3.1 Product launches 357 13.1.13.3.2 Expansions 358 13.1.14 CEVA SANTE ANIMALE 359 13.1.14.1 Business overview 359 13.1.14.2 Products offered 359 13.1.14.3 Recent developments 360 13.1.14.3.1 Deals 360 13.1.15 BIMEDA, INC. 361 13.1.15.1 Business overview 361 13.1.15.2 Products offered 361 13.1.15.3 Recent developments 362 13.1.15.3.1 Product launches 362 13.1.15.3.2 Deals 362 13.2 OTHER PLAYERS 363 13.2.1 INDIAN IMMUNOLOGICALS LTD. 363 13.2.2 VETANCO 364 13.2.3 CHANELLE PHARMA 365 13.2.4 PEGASUS LABORATORIES, INC. 366 13.2.5 KYORITSU SEIYAKU CORPORATION 367 13.2.6 AVET HEALTH 368 13.2.7 ANIMALDERMA SRLS 369 13.2.8 LETI PHARMA 370 13.2.9 HUVEPHARMA, INC. 371 13.2.10 VETPLUS 372 14 APPENDIX 373 14.1 DISCUSSION GUIDE 373 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 381 14.3 CUSTOMIZATION OPTIONS 383 14.4 RELATED REPORTS 383 14.5 AUTHOR DETAILS 384

TABLE 1 STANDARD CURRENCY CONVERSION RATES (UNIT OF USD) 35 TABLE 2 PET (DOGS AND CATS) OWNERSHIP STATISTICS IN US, 2024 66 TABLE 3 COMPANION ANIMAL POPULATION STATISTICS, BY REGION 67 TABLE 4 MAJOR OUTBREAKS OF ZOONOTIC DISEASES, 2022–2023 69 TABLE 5 AVERAGE ANNUAL PREMIUM: US AND CANADA (USD) 71 TABLE 6 VETERINARY DERMATOLOGY MARKET: IMPACT OF PORTER’S FIVE FORCES ANALYSIS 79 TABLE 7 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 85 TABLE 8 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 86 TABLE 9 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 87 TABLE 10 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 87 TABLE 11 VETERINARY DERMATOLOGY MARKET: LIST OF MAJOR PATENTS 90 TABLE 12 IMPORT DATA FOR PRODUCTS RELATED TO VETERINARY DERMATOLOGY, BY COUNTRY (2022–2024) (USD) 91 TABLE 13 EXPORT DATA FOR PRODUCTS RELATED TO VETERINARY DERMATOLOGY, BY COUNTRY (2022–2024) (USD) 91 TABLE 14 AVERAGE SELLING PRICE TRENDS OF KEY PLAYERS, BY PRODUCT TYPE, 2022–2024 93 TABLE 15 AVERAGE SELLING PRICE OF VETERINARY DERMATOLOGY PRODUCT TYPES, BY REGION, 2022–2024 94 TABLE 16 VETERINARY DERMATOLOGY MARKET: KEY CONFERENCES AND EVENTS (2025−2026) 96 TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT TYPE 97 TABLE 18 KEY BUYING CRITERIA FOR VETERINARY DERMATOLOGY PRODUCTS 98 TABLE 19 UNMET NEEDS/END USER EXPECTATIONS IN VETERINARY DERMATOLOGY MARKET 98 TABLE 20 VETERINARY DERMATOLOGY MARKET: IMPACT OF GENERATIVE AI 99 TABLE 21 VETERINARY DERMATOLOGY MARKET: ROLE OF COMPANIES IN ECOSYSTEM 100 TABLE 22 VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 109 TABLE 23 VETERINARY DERMATOLOGY MARKET: TOPICAL PRODUCTS AVAILABLE 110 TABLE 24 TOPICAL: VETERINARY DERMATOLOGY MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 112 TABLE 25 VETERINARY DERMATOLOGY MARKET: INJECTABLE PRODUCTS AVAILABLE 113 TABLE 26 INJECTABLES: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 114 TABLE 27 VETERINARY DERMATOLOGY MARKET: ORAL PRODUCTS AVAILABLE 115 TABLE 28 ORAL: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 116 TABLE 29 VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 118 TABLE 30 VETERINARY DERMATOLOGY MARKET: ANTIPARASITIC DRUGS AVAILABLE 119 TABLE 31 VOLUME DATA FOR ANTIPARASITIC DRUGS: VETERINARY DERMATOLOGY MARKET, BY REGION, 2023–2030 (THOUSAND UNITS) 120 TABLE 32 ANTIPARASITIC DRUGS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 121 TABLE 33 VETERINARY DERMATOLOGY MARKET: ANTIFUNGAL DRUGS AVAILABLE 122 TABLE 34 ANTIFUNGAL DRUGS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 124 TABLE 35 VETERINARY DERMATOLOGY MARKET: ANTIBACTERIAL DRUGS AVAILABLE 125 TABLE 36 ANTIBACTERIAL DRUGS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 126 TABLE 37 VETERINARY DERMATOLOGY MARKET: MONOCLONAL ANTIBODIES AVAILABLE 127 TABLE 38 MONOCLONAL ANTIBODIES: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 128 TABLE 39 VETERINARY DERMATOLOGY MARKET: OTHER PRODUCTS AVAILABLE 129 TABLE 40 OTHER PRODUCT TYPES: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 130 TABLE 41 VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION) 132 TABLE 42 PARASITIC INFECTIONS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 133 TABLE 43 INFECTIOUS DISEASES: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 135 TABLE 44 AUTOIMMUNE SKIN DISEASES: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 137 TABLE 45 SKIN CANCER: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 139 TABLE 46 OTHER CONDITION TYPES: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 141 TABLE 47 VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 143 TABLE 48 COMPANION ANIMALS: VETERINARY DERMATOLOGY MARKET, 2023–2030 (USD MILLION) 144 TABLE 49 COMPANION ANIMALS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 145 TABLE 50 DOGS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 147 TABLE 51 CATS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 149 TABLE 52 HORSES: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 151 TABLE 53 OTHER COMPANION ANIMALS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 153 TABLE 54 LIVESTOCK ANIMALS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 155 TABLE 55 CATTLE: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 157 TABLE 56 SWINE: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 159 TABLE 57 POULTRY: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 161 TABLE 58 OTHER LIVESTOCK ANIMALS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 163 TABLE 59 VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 165 TABLE 60 VETERINARY HOSPITALS AND CLINICS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 166 TABLE 61 ANIMAL SHELTERS AND RESCUES: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 168 TABLE 62 OTHER END USERS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 170 TABLE 63 VETERINARY DERMATOLOGY MARKET, BY REGION, 2023–2030 (USD MILLION) 173 TABLE 64 NORTH AMERICA: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 176 TABLE 65 NORTH AMERICA: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 176 TABLE 66 NORTH AMERICA: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 177 TABLE 67 NORTH AMERICA: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION) 177 TABLE 68 NORTH AMERICA: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 178 TABLE 69 NORTH AMERICA: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION) 178 TABLE 70 NORTH AMERICA: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION) 179 TABLE 71 NORTH AMERICA: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 179 TABLE 72 US: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 180 TABLE 73 US: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 181 TABLE 74 US: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION) 181 TABLE 75 US: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 182 TABLE 76 US: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION) 182 TABLE 77 US: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION) 182 TABLE 78 US: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 183 TABLE 79 CANADA: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 184 TABLE 80 CANADA: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 184 TABLE 81 CANADA: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION) 185 TABLE 82 CANADA: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 185 TABLE 83 CANADA: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION) 186 TABLE 84 CANADA: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION) 186 TABLE 85 CANADA: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 187 TABLE 86 EUROPE: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 189 TABLE 87 EUROPE: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 189 TABLE 88 EUROPE: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 190 TABLE 89 EUROPE: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION) 190 TABLE 90 EUROPE: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 191 TABLE 91 EUROPE: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION) 191 TABLE 92 EUROPE: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION) 192 TABLE 93 EUROPE: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 192 TABLE 94 GERMANY: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 193 TABLE 95 GERMANY: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 193 TABLE 96 GERMANY: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION) 194 TABLE 97 GERMANY: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 194 TABLE 98 GERMANY: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION) 195 TABLE 99 GERMANY: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION) 195 TABLE 100 GERMANY: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 196 TABLE 101 UK: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 197 TABLE 102 UK: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 197 TABLE 103 UK: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION) 198 TABLE 104 UK: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 198 TABLE 105 UK: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION) 199 TABLE 106 UK: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION) 199 TABLE 107 UK: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 200 TABLE 108 FRANCE: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 200 TABLE 109 FRANCE: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 201 TABLE 110 FRANCE: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION) 201 TABLE 111 FRANCE: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 202 TABLE 112 FRANCE: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION) 202 TABLE 113 FRANCE: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION) 203 TABLE 114 FRANCE: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 203 TABLE 115 ITALY: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 204 TABLE 116 ITALY: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 204 TABLE 117 ITALY: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION) 205 TABLE 118 ITALY: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 205 TABLE 119 ITALY: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION) 205 TABLE 120 ITALY: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION) 206 TABLE 121 ITALY: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 206 TABLE 122 SWITZERLAND: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 207 TABLE 123 SWITZERLAND: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 207 TABLE 124 SWITZERLAND: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION) 208 TABLE 125 SWITZERLAND: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 208 TABLE 126 SWITZERLAND: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION) 209 TABLE 127 SWITZERLAND: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION) 209 TABLE 128 SWITZERLAND: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 210 TABLE 129 SPAIN: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 210 TABLE 130 SPAIN: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 211 TABLE 131 SPAIN: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION) 211 TABLE 132 SPAIN: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 212 TABLE 133 SPAIN: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION) 212 TABLE 134 SPAIN: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION) 213 TABLE 135 SPAIN: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 213 TABLE 136 REST OF EUROPE: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 214 TABLE 137 REST OF EUROPE: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 214 TABLE 138 REST OF EUROPE: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION) 215 TABLE 139 REST OF EUROPE: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 215 TABLE 140 REST OF EUROPE: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION) 216 TABLE 141 REST OF EUROPE: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION) 216 TABLE 142 REST OF EUROPE: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 217 TABLE 143 ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 220 TABLE 144 ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 220 TABLE 145 ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 221 TABLE 146 ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION) 221 TABLE 147 ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 222 TABLE 148 ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION) 222 TABLE 149 ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION) 223 TABLE 150 ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 223 TABLE 151 JAPAN: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 224 TABLE 152 JAPAN: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 224 TABLE 153 JAPAN: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION) 225 TABLE 154 JAPAN: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 225 TABLE 155 JAPAN: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION) 226 TABLE 156 JAPAN: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION) 226 TABLE 157 JAPAN: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 227 TABLE 158 CHINA: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 228 TABLE 159 CHINA: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 228 TABLE 160 CHINA: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION) 229 TABLE 161 CHINA: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 229 TABLE 162 CHINA: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION) 230 TABLE 163 CHINA: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION) 230 TABLE 164 CHINA: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 231 TABLE 165 INDIA: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 232 TABLE 166 INDIA: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 232 TABLE 167 INDIA: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION) 233 TABLE 168 INDIA: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 233 TABLE 169 INDIA: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION) 234 TABLE 170 INDIA: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION) 234 TABLE 171 INDIA: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 235 TABLE 172 AUSTRALIA: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 235 TABLE 173 AUSTRALIA: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 236 TABLE 174 AUSTRALIA: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION) 236 TABLE 175 AUSTRALIA: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 237 TABLE 176 AUSTRALIA: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION) 237 TABLE 177 AUSTRALIA: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION) 238 TABLE 178 AUSTRALIA: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 238 TABLE 179 NEW ZEALAND: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 239 TABLE 180 NEW ZEALAND: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 239 TABLE 181 NEW ZEALAND: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION) 240 TABLE 182 NEW ZEALAND: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 240 TABLE 183 NEW ZEALAND: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION) 241 TABLE 184 NEW ZEALAND: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION) 241 TABLE 185 NEW ZEALAND: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 242 TABLE 186 SOUTH KOREA: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 242 TABLE 187 SOUTH KOREA: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 243 TABLE 188 SOUTH KOREA: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION) 243 TABLE 189 SOUTH KOREA: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 244 TABLE 190 SOUTH KOREA: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION) 244 TABLE 191 SOUTH KOREA: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION) 245 TABLE 192 SOUTH KOREA: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 245 TABLE 193 REST OF ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 246 TABLE 194 REST OF ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 246 TABLE 195 REST OF ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION) 247 TABLE 196 REST OF ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 247 TABLE 197 REST OF ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION) 248 TABLE 198 REST OF ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION) 248 TABLE 199 REST OF ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 249 TABLE 200 LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 250 TABLE 201 LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 251 TABLE 202 LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 251 TABLE 203 LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION) 252 TABLE 204 LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 252 TABLE 205 LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION) 253 TABLE 206 LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION) 253 TABLE 207 LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 254 TABLE 208 BRAZIL: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 255 TABLE 209 BRAZIL: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 255 TABLE 210 BRAZIL: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION) 256 TABLE 211 BRAZIL: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 256 TABLE 212 BRAZIL: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION) 257 TABLE 213 BRAZIL: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION) 257 TABLE 214 BRAZIL: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 258 TABLE 215 MEXICO: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 258 TABLE 216 MEXICO: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 259 TABLE 217 MEXICO: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION) 259 TABLE 218 MEXICO: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 260 TABLE 219 MEXICO: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION) 260 TABLE 220 MEXICO: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION) 260 TABLE 221 MEXICO: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 261 TABLE 222 REST OF LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 261 TABLE 223 REST OF LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 262 TABLE 224 REST OF LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION) 262 TABLE 225 REST OF LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 263 TABLE 226 REST OF LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION) 263 TABLE 227 REST OF LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION) 263 TABLE 228 REST OF LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 264 TABLE 229 MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 265 TABLE 230 MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 265 TABLE 231 MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION) 266 TABLE 232 MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 266 TABLE 233 MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION) 267 TABLE 234 MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION) 267 TABLE 235 MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 267 TABLE 236 GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 268 TABLE 237 GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 268 TABLE 238 GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 269 TABLE 239 GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION) 269 TABLE 240 GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 270 TABLE 241 GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION) 270 TABLE 242 GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION) 270 TABLE 243 GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 271 TABLE 244 KSA: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 271 TABLE 245 KSA: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 272 TABLE 246 KSA: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION) 272 TABLE 247 KSA: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 273 TABLE 248 KSA: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION) 273 TABLE 249 KSA: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION) 273 TABLE 250 KSA: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 274 TABLE 251 UAE: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 274 TABLE 252 UAE: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 275 TABLE 253 UAE: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION) 275 TABLE 254 UAE: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 276 TABLE 255 UAE: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION) 276 TABLE 256 UAE: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION) 276 TABLE 257 UAE: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 277 TABLE 258 REST OF GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 277 TABLE 259 REST OF GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 278 TABLE 260 REST OF GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION) 278 TABLE 261 REST OF GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 279 TABLE 262 REST OF GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION) 279 TABLE 263 REST OF GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION) 279 TABLE 264 REST OF GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 280 TABLE 265 REST OF MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 280 TABLE 266 REST OF MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 281 TABLE 267 REST OF MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION) 281 TABLE 268 REST OF MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 282 TABLE 269 REST OF MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION) 282 TABLE 270 REST OF MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION) 282 TABLE 271 REST OF MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 283 TABLE 272 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN VETERINARY DERMATOLOGY MARKET 284 TABLE 273 VETERINARY DERMATOLOGY MARKET: DEGREE OF COMPETITION 287 TABLE 274 VETERINARY DERMATOLOGY MARKET: REGION FOOTPRINT 292 TABLE 275 VETERINARY DERMATOLOGY MARKET: ROUTE OF ADMINISTRATION FOOTPRINT 293 TABLE 276 VETERINARY DERMATOLOGY MARKET: PRODUCT TYPE FOOTPRINT 294 TABLE 277 VETERINARY DERMATOLOGY MARKET: CONDITION TYPE FOOTPRINT 295 TABLE 278 VETERINARY DERMATOLOGY MARKET: ANIMAL TYPE FOOTPRINT 296 TABLE 279 VETERINARY DERMATOLOGY MARKET: LIST OF KEY STARTUPS/SMES 299 TABLE 280 VETERINARY DERMATOLOGY MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES 300 TABLE 281 VETERINARY DERMATOLOGY MARKET: PRODUCT APPROVALS/LAUNCHES, JANUARY 2021–JANUARY 2025 303 TABLE 282 VETERINARY DERMATOLOGY MARKET: DEALS, JANUARY 2021–JANUARY 2025 304 TABLE 283 VETERINARY DERMATOLOGY MARKET: EXPANSIONS, JANUARY 2021–JANUARY 2025 305 TABLE 284 VETERINARY DERMATOLOGY MARKET: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025 306 TABLE 285 ELANCO ANIMAL HEALTH INCORPORATED: COMPANY OVERVIEW 307 TABLE 286 ELANCO ANIMAL HEALTH INCORPORATED: PRODUCTS OFFERED 308 TABLE 287 ELANCO ANIMAL HEALTH INCORPORATED: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–JANUARY 2025 310 TABLE 288 ELANCO ANIMAL HEALTH INCORPORATED: DEALS, JANUARY 2021–JANUARY 2025 310 TABLE 289 ELANCO ANIMAL HEALTH INCORPORATED: EXPANSIONS, JANUARY 2021–JANUARY 2025 311 TABLE 290 MERCK & CO., INC: COMPANY OVERVIEW 313 TABLE 291 MERCK & CO., INC: PRODUCTS OFFERED 314 TABLE 292 MERCK & CO., INC: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–JANUARY 2025 315 TABLE 293 MERCK & CO., INC: DEALS, JANUARY 2021–JANUARY 2025 316 TABLE 294 MERCK & CO., INC: EXPANSIONS, JANUARY 2021–JANUARY 2025 317 TABLE 295 MERCK & CO., INC: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025 317 TABLE 296 VIRBAC: COMPANY OVERVIEW 319 TABLE 297 VIRBAC: PRODUCTS OFFERED 320 TABLE 298 VIRBAC: DEALS, JANUARY 2021–JANUARY 2025 321 TABLE 299 VIRBAC: EXPANSIONS, JANUARY 2021–JANUARY 2025 322 TABLE 300 VIRBAC: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025 322 TABLE 301 ZOETIS INC.: COMPANY OVERVIEW 324 TABLE 302 ZOETIS INC.: PRODUCTS OFFERED 325 TABLE 303 ZOETIS INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–JANUARY 2025 326 TABLE 304 ZOETIS INC.: DEALS, JANUARY 2021–JANUARY 2025 327 TABLE 305 ZOETIS INC.: EXPANSIONS, JANUARY 2021–JANUARY 2025 327 TABLE 306 ZOETIS INC.: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025 328 TABLE 307 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: COMPANY OVERVIEW 330 TABLE 308 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCTS OFFERED 331 TABLE 309 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCT APPROVALS, JANUARY 2021–JANUARY 2025 332 TABLE 310 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: DEALS, JANUARY 2021–JANUARY 2025 332 TABLE 311 VETOQUINOL: COMPANY OVERVIEW 334 TABLE 312 VETOQUINOL: PRODUCTS OFFERED 335 TABLE 313 VETOQUINOL: PRODUCT APPROVALS, JANUARY 2021–JANUARY 2025 336 TABLE 314 DECHRA PHARMACEUTICALS PLC: COMPANY OVERVIEW 337 TABLE 315 DECHRA PHARMACEUTICALS PLC: PRODUCTS OFFERED 338 TABLE 316 DECHRA PHARMACEUTICALS PLC: PRODUCT APPROVALS, JANUARY 2021–JANUARY 2025 339 TABLE 317 DECHRA PHARMACEUTICALS PLC: DEALS, JANUARY 2021–JANUARY 2025 340 TABLE 318 HESTER BIOSCIENCES LIMITED: COMPANY OVERVIEW 341 TABLE 319 HESTER BIOSCIENCES LIMITED: PRODUCTS OFFERED 343 TABLE 320 PETIQ, INC.: COMPANY OVERVIEW 344 TABLE 321 PETIQ, INC.: PRODUCTS OFFERED 345 TABLE 322 PETIQ, INC.: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025 346 TABLE 323 OUROFINO SAUDE ANIMAL: COMPANY OVERVIEW 347 TABLE 324 OUROFINO SAUDE ANIMAL: PRODUCTS OFFERED 348 TABLE 325 SWEDENCARE: COMPANY OVERVIEW 349 TABLE 326 SWEDENCARE: PRODUCTS OFFERED 350 TABLE 327 SWEDENCARE: DEALS, JANUARY 2021–JANUARY 2025 351 TABLE 328 ORION CORPORATION: COMPANY OVERVIEW 353 TABLE 329 ORION CORPORATION: PRODUCTS OFFERED 354 TABLE 330 NORBROOK: COMPANY OVERVIEW 355 TABLE 331 NORBROOK: PRODUCTS OFFERED 356 TABLE 332 NORBROOK: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025 357 TABLE 333 NORBROOK: EXPANSIONS, JANUARY 2021–JANUARY 2025 358 TABLE 334 CEVA SANTE ANIMALE: COMPANY OVERVIEW 359 TABLE 335 CEVA SANTE ANIMALE: PRODUCTS OFFERED 359 TABLE 336 CEVA SANTE ANIMALE: DEALS, JANUARY 2021–JANUARY 2025 360 TABLE 337 BIMEDA, INC.: COMPANY OVERVIEW 361 TABLE 338 BIMEDA, INC.: PRODUCTS OFFERED 361 TABLE 339 BIMEDA, INC.: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025 362 TABLE 340 BIMEDA, INC.: DEALS, JANUARY 2021–JANUARY 2025 362 _ FIGURE 1 VETERINARY DERMATOLOGY MARKET SCOPE AND REGIONS COVERED 34 FIGURE 2 RESEARCH DESIGN 37 FIGURE 3 PRIMARY SOURCES 41 FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 43 FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 44 FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 44 FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION 45 FIGURE 8 REVENUE ESTIMATION APPROACH: ZOETIS INC. 46 FIGURE 9 VETERINARY DERMATOLOGY MARKET (2024): SUPPLY-SIDE ANALYSIS 47 FIGURE 10 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023–2030) 48 FIGURE 11 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS 49 FIGURE 12 TOP-DOWN APPROACH 49 FIGURE 13 DATA TRIANGULATION METHODOLOGY 51 FIGURE 14 VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2025 VS. 2030 (USD MILLION) 54 FIGURE 15 VETERINARY DERMATOLOGY MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION) 55 FIGURE 16 VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2025 VS. 2030 (USD MILLION) 55 FIGURE 17 VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2025 VS. 2030 (USD MILLION) 56 FIGURE 18 VETERINARY DERMATOLOGY MARKET FOR COMPANION ANIMALS, 2025 VS. 2030 (USD MILLION) 57 FIGURE 19 VETERINARY DERMATOLOGY MARKET FOR LIVESTOCK ANIMALS, 2025 VS. 2030 (USD MILLION) 57 FIGURE 20 VETERINARY DERMATOLOGY MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 58 FIGURE 21 GEOGRAPHIC SNAPSHOT: ASIA PACIFIC TO WITNESS HIGHEST GROWTH RATE DURING FORECAST PERIOD 59 FIGURE 22 RISING PET POPULATION AND OWNERSHIP TO DRIVE VETERINARY DERMATOLOGY MARKET 60 FIGURE 23 ANTIPARASITIC DRUGS ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, IN 2024 61 FIGURE 24 NORTH AMERICA TO DOMINATE MARKET DURING FORECAST PERIOD 62 FIGURE 25 NEW ZEALAND TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 62 FIGURE 26 DEVELOPED MARKETS TO REGISTER HIGHER GROWTH THAN EMERGING MARKETS DURING FORECAST PERIOD 63 FIGURE 27 VETERINARY DERMATOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 65 FIGURE 28 PET POPULATION IN MAJOR MARKETS IN 2022 (MILLION) 66 FIGURE 29 EUROPE: PET POPULATION, 2021–2023 68 FIGURE 30 TOTAL INSURED PETS IN US, 2019–2023 71 FIGURE 31 TOTAL INSURED PETS IN CANADA, 2019–2023 71 FIGURE 32 TOTAL NUMBER OF VETERINARIANS IN US, BY GENDER, 2020–2023 74 FIGURE 33 NUMBER OF VETERINARIANS IN TOP 5 EUROPEAN COUNTRIES, 2023 75 FIGURE 34 VETERINARY DERMATOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS 82 FIGURE 35 DEVELOPMENT & APPROVAL PROCESS FOR ANIMAL PHARMACEUTICAL PRODUCTS 84 FIGURE 36 PATENT PUBLICATION TRENDS, JANUARY 2014–DECEMBER 2024 88 FIGURE 37 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR VETERINARY DERMATOLOGY PATENTS (JANUARY 2014–DECEMBER 2024) 89 FIGURE 38 TOP APPLICANT COUNTRIES/REGIONS FOR VETERINARY DERMATOLOGY PATENTS (JANUARY 2014–DECEMBER 2024) 89 FIGURE 39 AVERAGE SELLING PRICE TRENDS OF KEY PLAYERS, BY PRODUCT TYPE, 2022–2024 92 FIGURE 40 AVERAGE SELLING PRICE OF VETERINARY DERMATOLOGY PRODUCT TYPES, BY REGION, 2024 94 FIGURE 41 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT TYPE 97 FIGURE 42 KEY BUYING CRITERIA FOR VETERINARY DERMATOLOGY PRODUCTS 97 FIGURE 43 VETERINARY DERMATOLOGY MARKET: ECOSYSTEM ANALYSIS 100 FIGURE 44 VETERINARY DERMATOLOGY MARKET: SUPPLY CHAIN ANALYSIS 104 FIGURE 45 VETERINARY DERMATOLOGY MARKET: VALUE CHAIN ANALYSIS 105 FIGURE 46 ADJACENT MARKETS FOR VETERINARY DERMATOLOGY MARKET 105 FIGURE 47 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS IN VETERINARY DERMATOLOGY MARKET 106 FIGURE 48 INVESTMENT AND FUNDING ACTIVITIES IN VETERINARY DERMATOLOGY MARKET, 2020–2024 107 FIGURE 49 VETERINARY DERMATOLOGY MARKET, 2025–2030 172 FIGURE 50 GROWTH IN NUMBER OF VETERINARIANS IN NORTH AMERICA 174 FIGURE 51 NORTH AMERICA: PET POPULATION, 2024 174 FIGURE 52 NORTH AMERICA: NUMBER OF VETERINARIANS, 2023 175 FIGURE 53 NORTH AMERICA: VETERINARY DERMATOLOGY MARKET SNAPSHOT 175 FIGURE 54 US: TOTAL PET HEALTH EXPENDITURE (2018–2024) 180 FIGURE 55 EUROPE: PET POPULATION (MILLION), 2023 188 FIGURE 56 EUROPE: NUMBER OF VETERINARIANS, 2022 188 FIGURE 57 ASIA PACIFIC: DOG POPULATION, BY COUNTRY, 2024 218 FIGURE 58 ASIA PACIFIC: CAT POPULATION, BY COUNTRY, 2024 218 FIGURE 59 ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET SNAPSHOT 219 FIGURE 60 LATIN AMERICA: PET POPULATION, 2022 250 FIGURE 61 MIDDLE EAST & AFRICA: CAT POPULATION, 2024 265 FIGURE 62 REVENUE ANALYSIS OF KEY PLAYERS IN VETERINARY DERMATOLOGY MARKET (2020−2024) 286 FIGURE 63 SHARE ANALYSIS OF KEY PLAYERS IN VETERINARY DERMATOLOGY MARKET (2024) 287 FIGURE 64 RANKING OF KEY PLAYERS IN VETERINARY DERMATOLOGY MARKET, 2024 289 FIGURE 65 VETERINARY DERMATOLOGY MARKET: COMPANY EVALUATION MATRIX, 2024 290 FIGURE 66 VETERINARY DERMATOLOGY MARKET: COMPANY FOOTPRINT, 2024 291 FIGURE 67 VETERINARY DERMATOLOGY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 298 FIGURE 68 VETERINARY DERMATOLOGY MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 301 FIGURE 69 R&D EXPENDITURE OF KEY PLAYERS IN VETERINARY DERMATOLOGY MARKET, 2021−2023 302 FIGURE 70 EV/EBITDA FOR TOP COMPANIES 302 FIGURE 71 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 303 FIGURE 72 ELANCO ANIMAL HEALTH INCORPORATED: COMPANY SNAPSHOT (2024) 308 FIGURE 73 MERCK & CO., INC: COMPANY SNAPSHOT (2024) 314 FIGURE 74 VIRBAC: COMPANY SNAPSHOT (2023) 320 FIGURE 75 ZOETIS INC.: COMPANY SNAPSHOT (2024) 325 FIGURE 76 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: COMPANY SNAPSHOT (2023) 331 FIGURE 77 VETOQUINOL: COMPANY SNAPSHOT (2023) 335 FIGURE 78 DECHRA PHARMACEUTICALS PLC: COMPANY SNAPSHOT (2023) 338 FIGURE 79 HESTER BIOSCIENCES LIMITED: COMPANY SNAPSHOT (2023) 342 FIGURE 80 PETIQ, INC.: COMPANY SNAPSHOT (2023) 345 FIGURE 81 OUROFINO SAUDE ANIMAL: COMPANY SNAPSHOT (2023) 347 FIGURE 82 SWEDENCARE: COMPANY SNAPSHOT (2023) 350 FIGURE 83 ORION CORPORATION: COMPANY SNAPSHOT (2023) 354 FIGURE 84 NORBROOK: COMPANY SNAPSHOT (2023) 356

Single User Licence	$4,950 USD
Multi User Licence	$6,650 USD
Corporate User Licence	$8,150 USD
Global User Licence	$10,000 USD

Veterinary Dermatology Market by Route of Administration, Product type (Antibacterial, Antifungal, Antiparasitic Drugs, Monoclonal Antibodies), Condition type (Parasitic Infections, Infectious Diseases, Skin Cancer), Animal type - Global Forecast to 2030

授權報價

報告摘要

同分類最新報告（醫療器材）